O-GlcNAcomics-Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics

Proteomics - Clinical Applications

Volumn 7, Issue 9-10, 2013, Pages 597-606

  Copeland, Ronald J ^a   Han, Guanghui ^a   Hart, Gerald W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's; Cancer; Diabetes; Glycomics; O GlcNAc

Indexed keywords

CYCLIN DEPENDENT KINASE 1; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

ACYLATION; ALZHEIMER DISEASE; AMNESIA; BINDING AFFINITY; BINDING SITE; DISEASE COURSE; DOWN REGULATION; FUNCTIONAL PROTEOMICS; GENETIC CODE; GLYCOBIOLOGY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LEARNING DISORDER; LONG TERM MEMORY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOICHIOMETRY; UPREGULATION; ANIMAL; BRAIN; DIAGNOSTIC PROCEDURE; DISEASES; MEMORY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ACETYLGLUCOSAMINE; ANIMALS; BRAIN; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DISEASE; GLYCOMICS; HUMANS; MEMORY;

EID: 84884323220     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300001     Document Type: Review

References (71)

1. Hart, G. W., Housley, M. P., Slawson, C., Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007, 446, 1017-1022.
2. Slawson, C., Housley, M. P., Hart, G. W., O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J. Cell. Biochem. 2006, 97, 71-83.
3. Zeidan, Q., Hart, G. W., The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J. Cell Sci. 2010, 123, 13-22.
4. Bouche, C., Serdy, S., Kahn, C. R., Goldfine, A. B., The cellular fate of glucose and its relevance in type 2 diabetes. Endocr. Rev. 2004, 25, 807-830.
5. Hawkins, M., Barzilai, N., Liu, R., Hu, M. et al., Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 1997, 99, 2173-2182.
6. Marshall, S., Bacote, V., Traxinger, R. R., Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 1991, 266, 4706-4712.
7. Traxinger, R. R., Marshall, S., Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation. J. Biol. Chem. 1991, 266, 10148-10154.
8. Kreppel, L. K., Hart, G. W., Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 1999, 274, 32015-32022.
9. Haltiwanger, R. S., Blomberg, M. A., Hart, G. W., Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 1992, 267, 9005-9013.
10. Haltiwanger, R. S., Holt, G. D., Hart, G. W., Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 1990, 265, 2563-2568.
11. Dong, D. L., Hart, G. W., Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 1994, 269, 19321-19330.
12. Gao, Y., Wells, L., Comer, F. I., Parker, G. J. et al., Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 2001, 276, 9838-9845.
13. Blatch, G. L., Lassle, M., The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. BioEssays 1999, 21, 932-939.
14. Cheung, W. D., Sakabe, K., Housley, M. P., Dias, W. B. et al., O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J. Biol. Chem. 2008, 283, 33935-33941.
15. Lubas, W. A., Hanover, J. A., Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J. Biol. Chem. 2000, 275, 10983-10988.
16. Han, G., Ye, M., Jiang, X., Chen, R. et al., Comprehensive and reliable phosphorylation site mapping of individual phosphoproteins by combination of multiple stage mass spectrometric analysis with a target-decoy database search. Anal. Chem. 2009, 81, 5794-5805.
17. Han, G., Ye, M., Zhou, H., Jiang, X. et al., Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics 2008, 8, 1346-1361.
18. Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T. et al., A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143, 1174-1189.
19. Wu, R., Haas, W., Dephoure, N., Huttlin, E. L. et al., A large-scale method to measure absolute protein phosphorylation stoichiometries. Nat. Methods 2011, 8, 677-683.
20. Vosseller, K., Trinidad, J. C., Chalkley, R. J., Specht, C. G. et al., O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol. Cell. Proteomics 2006, 5, 923-934.
21. Trinidad, J. C., Barkan, D. T., Gulledge, B. F., Thalhammer, A. et al., Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol. Cell. Proteomics 2012, 11, 215-229.
22. Wang, Z., Park, K., Comer, F., Hsieh-Wilson, L. C. et al., Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Diabetes 2009, 58, 309-317.
23. Khidekel, N., Arndt, S., Lamarre-Vincent, N., Lippert, A. et al., A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications. J. Am. Chem. Soc. 2003, 125, 16162-16163.
24. Wang, Z., Udeshi, N. D., O'Malley, M., Shabanowitz, J. et al., Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry. Mol. Cell. Proteomics 2010, 9, 153-160.
25. Wang, Z., Udeshi, N. D., Slawson, C., Compton, P. D. et al., Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci. Signal. 2010, 3, ra2.
26. Alfaro, J. F., Gong, C. X., Monroe, M. E., Aldrich, J. T. et al., Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc. Natl. Acad. Sci. USA 2012, 109, 7280-7285.
27. Comer, F. I., Vosseller, K., Wells, L., Accavitti, M. A. et al., Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 2001, 293, 169-177.
28. Snow, C. M., Senior, A., Gerace, L., Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J. Cell Biol. 1987, 104, 1143-1156.
29. Holt, G. D., Haltiwanger, R. S., Torres, C. R., Hart, G. W., Erythrocytes contain cytoplasmic glycoproteins. O-linked GlcNAc on Band 4.1. J. Biol. Chem. 1987, 262, 14847-14850.
30. Rexach, J. E., Rogers, C. J., Yu, S. H., Tao, J. et al., Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat. Chem. Biol. 2010, 6, 645-651.
31. Rexach, J. E., Clark, P. M., Mason, D. E., Neve, R. L. et al., Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation. Nat. Chem. Biol. 2012, 8, 253-261.
32. Yi, W., Clark, P. M., Mason, D. E., Keenan, M. C. et al., Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 2012, 337, 975-980.
33. Caldwell, S. A., Jackson, S. R., Shahriari, K. S., Lynch, T. P. et al., Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 2010, 29, 2831-2842.
34. Gu, Y., Mi, W., Ge, Y., Liu, H. et al., GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res. 2010, 70, 6344-6351.
35. Slawson, C., Pidala, J., Potter, R., Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim. Biophys. Acta 2001, 1537, 147-157.
36. Bannon, J. H., Mc Gee, M. M., Understanding the role of aneuploidy in tumorigenesis. Biochem. Soc. Trans. 2009, 37, 910-913.
37. Ferrari, S., Protein kinases controlling the onset of mitosis. Cell. Mol. Life Sci. 2006, 63, 781-795.
38. Uyeda, K., Phosphofructokinase. Adv. Enzymol. Relat. Areas Mol. Biol. 1979, 48, 193-244.
39. Ferreras, C., Hernandez, E. D., Martinez-Costa, O. H., Aragon, J. J., Subunit interactions and composition of the fructose 6-phosphate catalytic site and the fructose 2, 6-bisphosphate allosteric site of mammalian phosphofructokinase. J. Biol. Chem. 2009, 284, 9124-9131.
40. Liu, F., Shi, J., Tanimukai, H., Gu, J. et al., Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 2009, 132, 1820-1832.
41. Yuzwa, S. A., Shan, X., Macauley, M. S., Clark, T. et al., Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat. Chem. Biol. 2012, 8, 393-399.
42. Arnold, C. S., Johnson, G. V., Cole, R. N., Dong, D. L. et al., The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J. Biol. Chem. 1996, 271, 28741-28744.
43. Dong, D. L., Xu, Z. S., Chevrier, M. R., Cotter, R. J. et al., Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J. Biol. Chem. 1993, 268, 16679-16687.
44. Griffith, L. S., Mathes, M., Schmitz, B., Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. J. Neurosci. Res. 1995, 41, 270-278.
45. Smet-Nocca, C., Broncel, M., Wieruszeski, J. M., Tokarski, C. et al., Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation. Mol. Biosyst. 2011, 7, 1420-1429.
46. Yuzwa, S. A., Yadav, A. K., Skorobogatko, Y., Clark, T. et al., Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody. Amino Acids 2011, 40, 857-868.
47. Robertson, L. A., Moya, K. L., Breen, K. C., The potential role of tau protein O-glycosylation in Alzheimer's disease. J. Alzheimers Dis. 2004, 6, 489-495.
48. Yu, Y., Zhang, L., Li, X., Run, X. et al., Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation. PLoS One 2012, 7, e35277.
49. Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X. et al., A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 2008, 4, 483-490.
50. Khidekel, N., Ficarro, S. B., Peters, E. C., Hsieh-Wilson, L. C., Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc. Natl. Acad. Sci. USA 2004, 101, 13132-13137.
51. Rexach, J., Clark, P., Hsieh-Wilson, L. C., Chemical approaches to understanding O-GlcNAc glycosylation in the brain. Nat. Chem. Biol. 2008, 4, 97-106.
52. Francisco, H., Kollins, K., Varghis, N., Vocadlo, D. et al., O-GlcNAc post-translational modifications regulate the entry of neurons into an axon branching program. Dev. Neurobiol. 2009, 69, 162-173.
53. Tallent, M. K., Varghis, N., Skorobogatko, Y., Hernandez-Cuebas, L. et al., In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. J. Biol. Chem. 2009, 284, 174-181.
54. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E. et al., The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112, 257-269.
55. Plath, N., Ohana, O., Dammermann, B., Errington, M. L. et al., Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 2006, 52, 437-444.
56. Wayman, G. A., Impey, S., Marks, D., Saneyoshi, T. et al., Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 2006, 50, 897-909.
57. Lamarre-Vincent, N., Hsieh-Wilson, L. C., Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. J. Am. Chem. Soc. 2003, 125, 6612-6613.
58. Housley, M. P., Rodgers, J. T., Udeshi, N. D., Kelly, T. J. et al., O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 2008, 283, 16283-16292.
59. Vosseller, K., Wells, L., Lane, M. D., Hart, G. W., Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 2002, 99, 5313-5318.
60. Macauley, M. S., Bubb, A., Martinez-Fleites, C., Davies, G. J. et al., Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J. Biol. Chem. 2008, 283, 34687-34695.
61. McClain, D. A., Lubas, W. A., Cooksey, R. C., Hazel, M. et al., Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc. Natl. Acad. Sci. USA 2002, 99, 10695-10699.
62. Dentin, R., Hedrick, S., Xie, J., Yates, J., III et al., Hepatic glucose sensing via the CREB coactivator CRTC2. Science 2008, 319, 1402-1405.
63. Lehman, D. M., Fu, D. J., Freeman, A. B., Hunt, K. J. et al., A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 2005, 54, 1214-1221.
64. Copeland, R. J., Bullen, J. W., Hart, G. W., Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E17-E28.
65. Yang, X., Ongusaha, P., Miles, P., Havstad, J. et al., Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 2008, 451, 964-970.
66. Ball, L. E., Berkaw, M. N., Buse, M. G., Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C-terminus of insulin receptor substrate-1. Mol. Cell. Proteomics 2006, 5, 313-323.
67. Klein, A. L., Berkaw, M. N., Buse, M. G., Ball, L. E., O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs. Mol. Cell. Proteomics 2009, 8, 2733-2745.
68. Whelan, S. A., Dias, W. B., Thiruneelakantapillai, L., Lane, M. D. et al., Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J. Biol. Chem. 2010, 285, 5204-5211.
69. Ruan, H. B., Han, X., Li, M. D., Singh, J. P. et al., O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1alpha stability. Cell Metab. 2012, 16, 226-237.
70. Park, K., Saudek, C. D., Hart, G. W., Increased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes. Diabetes 2010, 59, 1845-1850.
71. Springhorn, C., Matsha, T. E., Erasmus, R. T., Essop, M. F., Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2012, 97, 4640-4649.